Chile approves emergency use of Russian vaccine Sputnik V

Regulatory authorities of Chile approved this Wednesday the emergency use of the vaccine Russian Sputnik V in people over 18 years of age, the sixth to be certified for the fight against covid-19 in the country.

“The vaccine is safe and effective. All studies show that it has a good safety profile and most of the adverse events detected were mild,” said the director of the Institute of Public Health (ISP), Heriberto García.

Sputnik V, produced by the Russian laboratory Gamaleya, was approved by five votes in favor, two abstentions and one rejection by a panel of ISP experts.

The Russian vaccine joins the other five already approved in Chile: ls from Pfizer / BioNTech, Sinovac, AstraZeneca, CanSino and Johnson & Johnson, as recalled by the head of the ISP.

The vaccine is already applied in 70 countries – including Argentina, Brazil and Mexico – in two doses separated by 21 days to people over 18 years of age.

A tentative analysis of the Sputnik V phase III trial, published in February by the scientific journal The Lancet, suggests that the two-dose regimen of this drug offers 91.6% efficacy against symptomatic disease, a protection that rises to 91.8% in people over 60 years of age.

“All the studies show that the vaccine has a good safety profile, and most of the adverse events detected were mild, no unexpected adverse events were reported during clinical studies,” Garcia said.

The government of Sebastián Piñera must now determine whether to include the Russian vaccine in the successful vaccination program against the virus, through which 11.7 million people have already been inoculated with two doses, corresponding to 77.36% of the target population (15.2 million out of a total of 19 million inhabitants).

To this end, Chile has so far acquired more than 27 million vaccines: 6,101,940 from Pfizer-BioNTech, 18,671,476 from Sinovac, 575,908 from CanSino and 1,713,600 from AstraZeneca.

And it plans to receive between 3 and 4 million doses of the Russian vaccine in the coming months. So far, Johnson & Johnson’s are not being bought.


After 16 months of pandemic, Chile relaxed health measures this week after registering the lowest numbers of infections since November.

The Ministry of Health announced this Wednesday that another 989 cases were registered in the last 24 hours, and there are a total of 1,602,854 infections. Daily deaths totaled 42, and in total there are already 34,611 since the beginning of the pandemic.

The authorization of the Russian vaccine took place in parallel to the discussion carried out by the government about applying a third dose with the aim of preventing re-outbreaks, especially after the arrival of the delta variant, the most contagious according to the World Health Organization (WHO).

In Chile they have already been confirmed almost twenty cases of this variant, despite the fact that the borders have been closed since April except in cases of emergency.

After three months of a serious second wave that put the hospital system on the ropes, the pandemic remits in the country, which registered a drastic drop in the number of new infections and has had a positive rate in tests for more than two weeks. CRP below 5%.

Source: EFE and AFP



Leave a Comment